Th1high in Tumor Microenvironment is an Indicator of Poor Prognosis for Patients with NSCLC

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 Jan 7

PMID 28061450

Citations 17

Authors

Jian Huang

Fangrong Shen

Haitao Huang

Chunhua Ling

Guangbo Zhang

Affiliations

Soon will be listed here.

Abstract

CD4+Th subsets play an important role in tumor progression but their expression characteristics and clinical significance in human tumor microenvironment remains unclear. In this study, we aim to analyze the expression and clinical significance of tissue-infiltrating Th1, Th2 and Th17 in lung cancer by flow cytometry. We found that the frequency of CD3+CD4+IFN-γ+Th1 in tumor nest was significantly lower than that in tumor boundary, adjacent normal lung tissue or corresponding lymph node tissue; the frequency of CD3+CD4+IL-4+Th2 in tumor nest was significantly higher than that in tumor boundary, adjacent normal lung tissue or corresponding lymph node tissue; the frequency of CD3+CD4+IL-17+Th17 in tumor nest was significantly lower than that in tumor boundary, but not adjacent normal tissue or corresponding lymph node tissue. Survival analysis of 2-years survival after surgery showed that Th1high group was significantly lower compared with Th1low group; Th2high and Th17low is a good prognosis index compared with the Th2low and Th17high groups respectively, but this difference failed to significance. In addition, we also found that PD-1 expression showed a high level on lung tumor tissues and adjacent non- tumor tissue infiltrating T cells, and no significant difference was found between the two groups. However PD-L1 on CD45+CD14+mononcytes/macrophages in tumor tissue show a significantly higher level compared with that in adjacent nontumor tissues. In vitro stimulation experiments showed that IFN-γ could significantly increase PD-L1 expression on monocyte. In conclusion, we for the first time found Th1high is a poor indicator for prognosis of lung cancer.

Citing Articles

Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus.

Silva R, Lopes M, Travassos L Cancer Pathog Ther. 2024; 1(1):76-86.

PMID: 38328613 PMC: 10846313. DOI: 10.1016/j.cpt.2022.11.001.

Effect of Peripheral Blood Lymphocytes on Prognosis of Multiple Cancers.

Zhang X, Jing J Cancer Control. 2023; 30:10732748231202921.

PMID: 37815060 PMC: 10566274. DOI: 10.1177/10732748231202921.

Mechanisms of immune regulation for acupuncture on chronic respiratory diseases.

Meng W, Yu L, Chan X, Yefang L, Fanrong L, Bing M J Tradit Chin Med. 2022; 42(2):314-320.

PMID: 35473354 PMC: 9924721. DOI: 10.19852/j.cnki.jtcm.2022.02.009.

[Research Status of Tumor-associated Fibroblasts Regulating Immune Cells].

Mu G, Zhang W, Huang J, Chen Z, Wang J Zhongguo Fei Ai Za Zhi. 2022; 25(3):207-213.

PMID: 35340164 PMC: 8976201. DOI: 10.3779/j.issn.1009-3419.2022.101.04.

Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.

Li X, Liu Z, Zhou W, Liu X, Cao W BMC Cancer. 2021; 21(1):922.

PMID: 34391381 PMC: 8364714. DOI: 10.1186/s12885-021-08671-1.

References

Miossec P, Korn T, Kuchroo V . Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361(9):888-98. DOI: 10.1056/NEJMra0707449. View

Wakita D, Sumida K, Iwakura Y, Nishikawa H, Ohkuri T, Chamoto K . Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis. Eur J Immunol. 2010; 40(7):1927-37. DOI: 10.1002/eji.200940157. View

Wilson J, Balkwill F . The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol. 2002; 12(2):113-20. DOI: 10.1006/scbi.2001.0419. View

Wang K, Kim M, Caro G, Wong J, Shalapour S, Wan J . Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity. 2014; 41(6):1052-63. PMC: 4272447. DOI: 10.1016/j.immuni.2014.11.009. View

Abbas A, Murphy K, Sher A . Functional diversity of helper T lymphocytes. Nature. 1996; 383(6603):787-93. DOI: 10.1038/383787a0. View

Joyce J, Pollard J . Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009; 9(4):239-52. PMC: 3251309. DOI: 10.1038/nrc2618. View

Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F . IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005; 175(9):6177-89. DOI: 10.4049/jimmunol.175.9.6177. View

Su Z, Sun Y, Zhu H, Liu Y, Lin X, Shen H . Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res. 2014; 58(1):118-24. DOI: 10.1007/s12026-013-8483-y. View

Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G . Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res. 2011; 71(4):1263-71. DOI: 10.1158/0008-5472.CAN-10-2907. View

10.

Zou W, Restifo N . T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol. 2010; 10(4):248-56. PMC: 3242804. DOI: 10.1038/nri2742. View

11.

Zhou L, Chong M, Littman D . Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009; 30(5):646-55. DOI: 10.1016/j.immuni.2009.05.001. View

12.

Zhang G, Huang H, Zhu Y, Yu G, Gao X, Xu Y . A novel subset of B7-H3CD14HLA-DR myeloid-derived suppressor cells are associated with progression of human NSCLC. Oncoimmunology. 2015; 4(2):e977164. PMC: 4404793. DOI: 10.4161/2162402X.2014.977164. View

13.

Ma C, Tangye S, Deenick E . Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21. Immunol Cell Biol. 2010; 88(6):621-3. DOI: 10.1038/icb.2010.73. View

14.

Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S . Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009; 119(12):3573-85. PMC: 2786807. DOI: 10.1172/JCI40202. View

15.

Shi L, Wang L, Hou J, Zhu B, Min Z, Zhang M . Targeting roles of inflammatory microenvironment in lung cancer and metastasis. Cancer Metastasis Rev. 2015; 34(2):319-31. DOI: 10.1007/s10555-015-9570-4. View

16.

Gaur P, Singh A, Shukla N, Das S . Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance. Hum Immunol. 2014; 75(4):330-7. DOI: 10.1016/j.humimm.2014.01.011. View

17.

Feng P, Yan R, Dai X, Xie X, Wen H, Yang S . The alteration and clinical significance of Th1/Th2/Th17/Treg cells in patients with multiple myeloma. Inflammation. 2014; 38(2):705-9. DOI: 10.1007/s10753-014-9980-4. View

18.

Xiao M, Wang C, Zhang J, Li Z, Zhao X, Qin Z . IFNgamma promotes papilloma development by up-regulating Th17-associated inflammation. Cancer Res. 2009; 69(5):2010-7. DOI: 10.1158/0008-5472.CAN-08-3479. View

19.

Refaeli Y, Van Parijs L, Alexander S, Abbas A . Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med. 2002; 196(7):999-1005. PMC: 2194022. DOI: 10.1084/jem.20020666. View

20.

Zhu J, Paul W . Heterogeneity and plasticity of T helper cells. Cell Res. 2009; 20(1):4-12. PMC: 3494736. DOI: 10.1038/cr.2009.138. View